These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25226709)
1. Novel psychoactive substances: risks and harms. O'Neill C Community Pract; 2014 Aug; 87(8):45-7. PubMed ID: 25226709 [No Abstract] [Full Text] [Related]
2. Novel psychoactive substances: the rising wave of 'legal highs'. Gilani F Br J Gen Pract; 2016 Jan; 66(642):8-9. PubMed ID: 26719457 [No Abstract] [Full Text] [Related]
3. [Smart drugs. Patent medicines at the borderline to drugs]. Katzung W Med Monatsschr Pharm; 1993 Jun; 16(6):172-5. PubMed ID: 8332099 [No Abstract] [Full Text] [Related]
4. Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study. Jouanjus E; Falcou A; Deheul S; Roussin A; Lapeyre-Mestre M Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1286-1292. PubMed ID: 30255533 [TBL] [Abstract][Full Text] [Related]
5. Use of psychoactive substances among patients presenting at the emergency department of a tertiary hospital. Dapap DD; Okpataku CI; Audu MD Niger Postgrad Med J; 2020; 27(3):230-236. PubMed ID: 32687124 [TBL] [Abstract][Full Text] [Related]
6. "Smart drugs": a caution to everybody. Baker LS Am J Psychiatry; 1996 Jun; 153(6):844-5. PubMed ID: 8633714 [No Abstract] [Full Text] [Related]
7. Editorial to Methamphetamine ("Crystal meth") and New Psychoactive Substances. Zimmermann US Pharmacopsychiatry; 2017 May; 50(3):85-86. PubMed ID: 28351079 [No Abstract] [Full Text] [Related]
8. The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population. KimergÄrd A; Foley M; Davey Z; Wadsworth E; Drummond C; Deluca P Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597537 [TBL] [Abstract][Full Text] [Related]
9. Abuse of inhalants: a review. Dinwiddie SH Addiction; 1994 Aug; 89(8):925-39. PubMed ID: 7950851 [TBL] [Abstract][Full Text] [Related]
11. [Somatic and neurological disorders in psychoactive substance addiction]. Nikiforov IA Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(8):65-73. PubMed ID: 16972601 [No Abstract] [Full Text] [Related]
12. Substance misuse by the elderly. Ghodse AH Br J Hosp Med; 1997 Nov 5-18; 58(9):451-3. PubMed ID: 9619207 [No Abstract] [Full Text] [Related]
13. [Health food preparations are not harmless. Ask about over-the-counter drugs and dietary supplements during every medication anamnesis]. Böttiger Y Lakartidningen; 2007 Mar 7-13; 104(10):764. PubMed ID: 17432792 [No Abstract] [Full Text] [Related]
14. Managing misuse of novel psychoactive substances. Solomon D; Grewal P; Taylor C; Solomon B Nurs Times; 2014 May 28-Jun 3; 110(22):12-5. PubMed ID: 24984370 [TBL] [Abstract][Full Text] [Related]
15. Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study. Ahmad K; Aziz Z J Ethnopharmacol; 2012 May; 141(1):446-50. PubMed ID: 22440259 [TBL] [Abstract][Full Text] [Related]
16. [Psychoactive substance in the workplace]. Warnet S Rev Infirm; 2012 Mar; (179):8. PubMed ID: 22506364 [No Abstract] [Full Text] [Related]
18. Psychoactive abuse potential of Robitussin-DM. Helfer J; Kim OM Am J Psychiatry; 1990 May; 147(5):672-3. PubMed ID: 2327500 [No Abstract] [Full Text] [Related]
19. The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan. Tanibuchi Y; Matsumoto T; Funada D; Shimane T Neuropsychopharmacol Rep; 2018 Dec; 38(4):189-196. PubMed ID: 30341809 [TBL] [Abstract][Full Text] [Related]